{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:26:31Z","timestamp":1791141991844,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":593,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bpg.2011.10.009","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T15:44:43Z","timestamp":1322667883000},"page":"727-739","source":"Crossref","is-referenced-by-count":110,"title":["Pathogenesis of primary sclerosing cholangitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Marion J.","family":"Pollheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Halilbasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2011.10.009_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/bega.2001.0204","article-title":"Epidemiology of primary sclerosing cholangitis","volume":"15","author":"Schrumpf","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.51.4.567","article-title":"Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study","volume":"51","author":"Mitchell","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O\u2019Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib4","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3748\/wjg.14.3350","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"14","author":"Chapman","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00365528209182038","article-title":"HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease","volume":"17","author":"Schrumpf","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrg1489","article-title":"Gene map of the extended human MHC","volume":"5","author":"Horton","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bpg.2011.10.009_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpg.2011.10.009_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/gut.24.1.38","article-title":"Association of primary sclerosing cholangitis with HLA-B8","volume":"24","author":"Chapman","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1699-0463.1995.tb01400.x","article-title":"HLA antigens in ulcerative colitis and primary sclerosing cholangitis","volume":"103","author":"Leidenius","year":"1995","journal-title":"APMIS"},{"key":"10.1016\/j.bpg.2011.10.009_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1440-1746.1990.tb01818.x","article-title":"Primary sclerosing cholangitis: clinical and immunopathological review of 21 cases","volume":"5","author":"Jeffrey","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1590-8658(03)00274-3","article-title":"Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population","volume":"35","author":"Neri","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/gut.51.4.609","article-title":"Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1\u221713 but not with tumour necrosis factor alpha -308 promoter polymorphism","volume":"51","author":"Bittencourt","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.510280309","article-title":"Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis","volume":"28","author":"Moloney","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/gast.2001.24041","article-title":"Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism","volume":"120","author":"Norris","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/jhep.2001.27543","article-title":"Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles","volume":"34","author":"Wiencke","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","volume":"49","author":"Mitchell","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bpg.2011.10.009_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.1840160217","article-title":"Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis","volume":"16","author":"Farrant","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-009-0154-7","article-title":"The immunobiology of primary sclerosing cholangitis","volume":"31","author":"Aron","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.bpg.2011.10.009_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2005.07.013","article-title":"Do NK cells regulate human autoimmunity?","volume":"32","author":"Pazmany","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.bpg.2011.10.009_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2007.01.032","article-title":"Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis","volume":"46","author":"Karlsen","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.gene.6364377","article-title":"Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis","volume":"8","author":"Karlsen","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.bpg.2011.10.009_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.1840140305","article-title":"Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"14","author":"Adams","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0168-8278(96)80292-3","article-title":"Increased intercellular adhesion molecule-1 serum concentration in cholestasis","volume":"25","author":"Polzien","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2003.11.009","article-title":"Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1","volume":"40","author":"Yang","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2006.03.012","article-title":"Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis","volume":"45","author":"Bowlus","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib31","doi-asserted-by":"crossref","first-page":"40133","DOI":"10.1074\/jbc.M105722200","article-title":"A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression","volume":"276","author":"Venkatesan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpg.2011.10.009_bib32","first-page":"174A","article-title":"Investigation of CCR5 Delta 32 deletion and FAS\/APO-1 (CD95) single nucleotide polymorphisms in primary sclerosing cholangitis (PSC)","volume":"32","author":"Donaldson","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib33","doi-asserted-by":"crossref","first-page":"A337","DOI":"10.1016\/S0016-5085(00)83443-5","article-title":"CCR5\u039432 polymorphism in inflammatory bowel disease: further association with ulcerative colitis and with primary sclerosing cholangitis","volume":"118","author":"Satsangi","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/sj.gene.6364113","article-title":"CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis","volume":"5","author":"Eri","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.bpg.2011.10.009_bib35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.MIB.0000209790.21737.28","article-title":"CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis","volume":"12","author":"Henckaerts","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-0039.2006.00604.x","article-title":"The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients","volume":"68","author":"Melum","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bpg.2011.10.009_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bpg.2011.10.009_bib38","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1371\/journal.pone.0012403","article-title":"Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis","volume":"5","author":"Hov","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2011.10.009_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bpg.2011.10.009_bib41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/gut.52.5.759","article-title":"Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?","volume":"52","author":"Ho","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1572-0241.2006.00928.x","article-title":"Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis","volume":"102","author":"Karlsen","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib43","doi-asserted-by":"crossref","unstructured":"Zintzaras E. Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease? Inflamm Bowel Dis. in press.","DOI":"10.1002\/ibd.21728"},{"key":"10.1016\/j.bpg.2011.10.009_bib44","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1210\/me.2005-0156","article-title":"The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges","volume":"19","author":"Orans","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bpg.2011.10.009_bib45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/87856","article-title":"Promiscuous regulator of xenobiotic removal","volume":"7","author":"Schuetz","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2011.10.009_bib46","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bpg.2011.10.009_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2004.04.019","article-title":"Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes","volume":"127","author":"Langmann","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1600-0676.2001.021004247.x","article-title":"Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis","volume":"21","author":"Oswald","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.bpg.2011.10.009_bib49","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/ibd.21562","article-title":"Pregnane X receptor (PXR\/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease","volume":"17","author":"Glas","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1053\/j.gastro.2006.05.057","article-title":"Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis","volume":"131","author":"Karlsen","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9610(65)90018-8","article-title":"Sclerosing cholangitis; review of recent case reports and associated diseases and four new cases","volume":"110","author":"Smith","year":"1965","journal-title":"Am J Surg"},{"key":"10.1016\/j.bpg.2011.10.009_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0676.2000.020002097.x","article-title":"Liver transplantation for primary sclerosing cholangitis","volume":"20","author":"Gow","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.bpg.2011.10.009_bib54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00365528709011139","article-title":"Primary sclerosing cholangitis: a long-term follow-up study","volume":"22","author":"Aadland","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jhep.2008.07.002","article-title":"Pathogenesis of primary sclerosing cholangitis","volume":"49","author":"Cholongitas","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib56","doi-asserted-by":"crossref","unstructured":"J\u00f8rgensen KK, Grzyb K, Lundin KE, et\u00a0al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. in press.","DOI":"10.1002\/ibd.21699"},{"key":"10.1016\/j.bpg.2011.10.009_bib57","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/BF02919752","article-title":"Hepatobiliary injury associated with experimental small-bowel bacterial overgrowth in rats","volume":"10","author":"Lichtman","year":"1991","journal-title":"Immunol Res"},{"key":"10.1016\/j.bpg.2011.10.009_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02365447","article-title":"Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats","volume":"29","author":"Yamada","year":"1994","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib59","doi-asserted-by":"crossref","unstructured":"Pollheimer MJ, Trauner M, Fickert P. Will we ever model PSC? - \"It\u2019s hard to be a PSC model!\" Clin Res Hepatol Gastroenterol. in press.","DOI":"10.1016\/j.clinre.2011.04.014"},{"key":"10.1016\/j.bpg.2011.10.009_bib60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/pgmj.37.427.245","article-title":"A study of liver disorder in ulcerative colitis","volume":"37","author":"Brooke","year":"1961","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bpg.2011.10.009_bib61","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers","volume":"28","author":"Olsson","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib62","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/00365520510023288","article-title":"Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib63","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/imj.1965.14.4.286","article-title":"Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis","volume":"14","author":"Mistilis","year":"1965","journal-title":"Australas Ann Med"},{"key":"10.1016\/j.bpg.2011.10.009_bib64","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"F\u00e4rkkil\u00e4","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-230X-2-14","article-title":"Bacterial cholangitis causing secondary sclerosing cholangitis: a case report","volume":"2","author":"ter Borg","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib66","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.10.009_bib67","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2009.02.046","article-title":"Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells","volume":"137","author":"Eksteen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7861\/clinmedicine.4-2-173","article-title":"Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease","volume":"4","author":"Eksteen","year":"2004","journal-title":"Clin Med"},{"key":"10.1016\/j.bpg.2011.10.009_bib69","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib70","series-title":"MacSween\u2019s pathology of the liver","first-page":"549","article-title":"Diseases of the bile ducts","author":"Portmann","year":"2007"},{"key":"10.1016\/j.bpg.2011.10.009_bib71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0168-8278(86)80483-4","article-title":"Expression of MHC products by normal and abnormal bile duct epithelium","volume":"3","author":"Van den Oord","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib72","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib73","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system. second of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2011.10.009_bib74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","author":"Bo","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib75","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hep.1840050321","article-title":"Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis","volume":"5","author":"Whiteside","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib76","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0025-6196(12)60897-0","article-title":"Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis","volume":"68","author":"Hashimoto","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bpg.2011.10.009_bib77","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/BF01296138","article-title":"Lymphocyte subsets in primary sclerosing cholangitis","volume":"32","author":"Lindor","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.10.009_bib78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib79","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy","volume":"18","author":"Bj\u00f6rnsson","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.bpg.2011.10.009_bib80","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib81","first-page":"490A","article-title":"High prevalence of IgG4 positive immunohistochemical cholangitis in liver explants from patients with PSC","volume":"52","author":"Ali","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib82","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib83","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/bega.2001.0209","article-title":"Anti-neutrophil antibodies in primary sclerosing cholangitis","volume":"15","author":"Terjung","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.009_bib84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2249.2003.02195.x","article-title":"IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis","volume":"133","author":"Schwarze","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bpg.2011.10.009_bib85","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8088-8","article-title":"Atypical p-ANCA in PSC and AIH: a hint toward a \"leaky gut\u201d","volume":"36","author":"Terjung","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bpg.2011.10.009_bib86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2249.1996.tb08293.x","article-title":"Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis","volume":"103","author":"Zhao","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bpg.2011.10.009_bib87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2249.1995.tb03471.x","article-title":"Bactericidal\/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis","volume":"99","author":"Zhao","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bpg.2011.10.009_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.1992.tb05835.x","article-title":"Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn\u2019s disease and primary sclerosing cholangitis","volume":"90","author":"Halbwachs-Mecarelli","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bpg.2011.10.009_bib89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/gut.34.1.56","article-title":"Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn\u2019s disease","volume":"34","author":"Peen","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib90","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.51.1.120","article-title":"High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6","volume":"51","author":"Xu","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.009_bib91","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2007.01.039","article-title":"Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis","volume":"132","author":"Karrar","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib92","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bpg.2011.10.009_bib93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib94","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0002-9440(10)63234-8","article-title":"Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model","volume":"164","author":"Durie","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2011.10.009_bib95","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5085(99)70464-6","article-title":"Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria","volume":"117","author":"Meerman","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.1257","article-title":"Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria","volume":"199","author":"Libbrecht","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.bpg.2011.10.009_bib97","series-title":"Defects in hepatobiliary transport. genetics and therapy of progressive familial intrahepatic cholestasis type 3","author":"deVree","year":"1999"},{"key":"10.1016\/j.bpg.2011.10.009_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib99","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","article-title":"BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Pauli-Magnus","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1478-3231.2009.02044.x","article-title":"Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice","volume":"29","author":"Jahnel","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2011.10.009_bib101","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.257.5073.1083","article-title":"An animal model for cystic fibrosis made by gene targeting","volume":"257","author":"Snouwaert","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bpg.2011.10.009_bib102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/359211a0","article-title":"Cystic fibrosis in the mouse by targeted insertional mutagenesis","volume":"359","author":"Dorin","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2011.10.009_bib103","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng0895-445","article-title":"Generation and characterization of a delta F508 cystic fibrosis mouse model","volume":"10","author":"Colledge","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpg.2011.10.009_bib104","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI118253","article-title":"A mouse model for the delta F508 allele of cystic fibrosis","volume":"96","author":"Zeiher","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2011.10.009_bib105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0168-8278(02)00161-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis","volume":"37","author":"Girodon","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib106","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1053\/j.gastro.2011.06.052","article-title":"Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-\u03baB-Mediated inflammatory response in mice","volume":"141","author":"Fiorotto","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib107","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2008.07.033","article-title":"Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis","volume":"50","author":"Henckaerts","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib108","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","article-title":"A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis","volume":"171","author":"Fickert","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2011.10.009_bib109","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","article-title":"Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice","volume":"168","author":"Fickert","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2011.10.009_bib110","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1053\/j.gastro.2011.06.078","article-title":"Protoporphyrin retention in hepatocytes and kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model","volume":"141","author":"Lyoumi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib111","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1440-1827.1998.tb03927.x","article-title":"Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graft-versus-host disease in mice","volume":"48","author":"Nonomura","year":"1998","journal-title":"Pathol Int"},{"key":"10.1016\/j.bpg.2011.10.009_bib112","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1172-1-41","article-title":"Primary sclerosing cholangitis","volume":"1","author":"Worthington","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib113","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2004.04.024","article-title":"Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients","volume":"41","author":"Wiencke","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib114","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/gast.2001.25527","article-title":"A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis","volume":"121","author":"Satsangi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.009_bib115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0168-8278(95)80432-3","article-title":"Induction of chronic cholangitis in the rat by trinitrobenzenesulfonic acid","volume":"22","author":"Mourelle","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib116","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0168-8278(00)80116-6","article-title":"A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated BD is associated with increased TNF-alpha production and autoantibodies","volume":"33","author":"Orth","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib117","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1076-6332(05)80410-6","article-title":"A microcholangiographic study of liver disease models in rats","volume":"2","author":"Lichtman","year":"1995","journal-title":"Acad Radiol"},{"key":"10.1016\/j.bpg.2011.10.009_bib118","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.510300138","article-title":"Liver and bile duct pathology following cryptosporidium parvum infection of immunodeficient mice","volume":"30","author":"Stephens","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.009_bib119","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/IAI.58.4.961-969.1990","article-title":"New mouse models for chronic cryptosporidium infection in immunodeficient hosts","volume":"58","author":"Ungar","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.bpg.2011.10.009_bib120","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/infdis\/163.6.1297","article-title":"Chronic cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice","volume":"163","author":"Mead","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpg.2011.10.009_bib121","first-page":"959","article-title":"Chronic active hepatitis in mice caused by Helicobacter hepaticus","volume":"145","author":"Ward","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2011.10.009_bib122","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.6050","article-title":"Characterization of time-related changes after experimental bile duct ligation","volume":"95","author":"Georgiev","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.bpg.2011.10.009_bib123","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1440-1746.2003.03333.x","article-title":"Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium","volume":"19","author":"Numata","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.009_bib124","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1023\/A:1015330809095","article-title":"Experimental colitis attenuates development of toxin-induced cholangitis in rats","volume":"47","author":"Tjandra","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.10.009_bib125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2362.1999.00547.x","article-title":"Anti-neutrophil cytoplasmic antibodies in a rat model of trinitrobenzenesulphonic acid-induced liver injury","volume":"29","author":"Orth","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.bpg.2011.10.009_bib126","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jhep.2004.10.025","article-title":"Adaptative bile duct proliferative response in experimental bile duct ischemia","volume":"42","author":"Beaussier","year":"2005","journal-title":"J Hepatol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T02:52:17Z","timestamp":1593312737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691811000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":126,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1521691811000977"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2011.10.009","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}